本文翻译正在准备中。在此之前，我们暂时显示英文原文。
商业 · 2006/6/81 分钟阅读
Oral Dosage Form New Animal Drugs; Oxibendazole Suspension
本地自动翻译 · 来源原始语言
摘要
The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Pfizer, Inc. The supplemental NADA provides for revised food safety labeling for oxibendazole suspension administered orally to horses as an antiparasitic.
来源原始语言: Federal Register — Food and Drug Administration打开原始公告 →